Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Guangzhou Jet Biofiltration Co's Revenue for the
three
months ended in Jun. 2026 was ¥169.6 Mil. Guangzhou Jet Biofiltration Co's average Accounts Receivable for the
three
months ended in Jun. 2026 was ¥116.7 Mil.
Hence, Guangzhou Jet Biofiltration Co's Receivables Turnover for the
three
months ended in Jun. 2026 was 1.45.
Guangzhou Jet Biofiltration Co (SHSE:688026) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Guangzhou Jet Biofiltration Co Receivables Turnover Related Terms
Guangzhou Jet Biofiltration Co Receivables Turnover Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangzhou Jet Biofiltration Co Receivables Turnover Chart
SHSE:688026 vs ISRG, BDX, RMD: Receivables Turnover Comparison
For the Medical Instruments & Supplies subindustry, Guangzhou Jet Biofiltration Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guangzhou Jet Biofiltration Co Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Guangzhou Jet Biofiltration Co's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Guangzhou Jet Biofiltration Co's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangzhou Jet Biofiltration Co (SHSE:688026) has a Receivables Turnover of 1.45 as of Jun. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Guangzhou Jet Biofiltration Co and its competitors. According to the industry distribution chart, Guangzhou Jet Biofiltration Co ranks #546 out of 810 companies in the Medical Devices & Instruments industry, placing it in the top 67.4%.
Is Guangzhou Jet Biofiltration Co's Receivables Turnover too high?
Guangzhou Jet Biofiltration Co's current Receivables Turnover is 1.45. The Medical Devices & Instruments industry median Receivables Turnover is 5.62. Guangzhou Jet Biofiltration Co's value of 1.45 is 74.2% below this industry median. Based on the distribution chart, Guangzhou Jet Biofiltration Co ranks #546 out of 810 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Guangzhou Jet Biofiltration Co has a GF Score™ of 74/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Guangzhou Jet Biofiltration Co's Receivables Turnover compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Guangzhou Jet Biofiltration Co ranks #546 out of 810 companies for Receivables Turnover. This places Guangzhou Jet Biofiltration Co in the lower half of its industry. The industry median Receivables Turnover is 5.62. Guangzhou Jet Biofiltration Co's value of 1.45 is 74.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.62, based on 810 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guangzhou Jet Biofiltration Co's current Receivables Turnover of 1.45 is 74.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Guangzhou Jet Biofiltration Co and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guangzhou Jet Biofiltration Co's current Receivables Turnover is 1.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangzhou Jet Biofiltration Co stock overvalued right now?
Based on GuruFocus' analysis, Guangzhou Jet Biofiltration Co (SHSE:688026) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥17.67, compared to a current price of ¥21.63 — trading 22.4% above its estimated fair value. The current Receivables Turnover is 1.45 and 74.2% below the Medical Devices & Instruments industry median of 5.62. Guangzhou Jet Biofiltration Co's overall GF Score™ is 74/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Guangzhou Jet Biofiltration Co (SHSE:688026), the current Receivables Turnover is 1.45 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guangzhou Jet Biofiltration Co (SHSE:688026) Overvalued in 2026?
Based on GuruFocus' analysis, Guangzhou Jet Biofiltration Co stock appears to be overvalued.
The current stock price of ¥21.63 is trading 22.4% above its estimated GF Value™ of ¥17.67.
GuruFocus considers Guangzhou Jet Biofiltration Co to be Modestly Overvalued.
Key valuation signals for SHSE:688026:
Receivables Turnover: 1.45
GF Value™: ¥17.67 vs. price of ¥21.63 (22.4% above fair value)
Industry Position: 74.2% below the Medical Devices & Instruments median (#546 of 810)
No single metric tells the full story. See the SHSE:688026 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Guangzhou Jet Biofiltration Co Ltd is engaged in the research and development, manufacturing and sales of laboratory consumable products. Its main products include laboratory consumables (pipettes, tissue culture products, centrifuge tubes, filtration products) analyzer, lab equipment and others.
74GF Score
Get the complete analysis for SHSE:688026
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688026 has been successfully added to your 
